Buprenorphine HCl and Naloxone HCl
NDC 50268-144, Buprenorphine and Naloxone, tablet, from AvPAK.
- Product NDC
- 50268-144
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203136
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/50268-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-144-15 | 50268014415 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-144-15) / 1 TABLET in 1 BLISTER PACK (50268-144-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b955054b-b37d-4079-4fed-5939b763ecb4NADAC price for package 50268014415
GET /v1/drugs/nadac/50268014415
Use it
Look up 50268-144 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.